Saudi Arabia Pharmaceuticals Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 1,800.00$ 6,900.00

Saudi Arabia Pharmaceuticals Market: By Product Type (Prescription Products and OTC Products), By Diseases Type (Diabetes, Cardiovascular Diseases, Cancer, Neurological Disorders, Obesity, Infectious Diseases, and Others), By Distribution Channel (Hospital Pharmacies and Retail Pharmacies).

$ PRICE - $ 1,800.00$ 6,900.00
Clear selection
Clear
$ PRICE - $ 1,800.00$ 6,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Saudi Arabia Pharmaceuticals Market size was valued at USD 7,979.17 million in 2021 and is expected to reach USD 12,646.10 million by 2028, at a CAGR of 6.8% during the forecast period 2022 to 2028. The desire for branded or second-generation pharmaceuticals among key stakeholders such as patients and prescribers is creating a plethora of opportunities for global companies in the country. These brands are typically distributed through partnerships with local pharmaceutical businesses, which enable new entrants into the market to access a larger number of pharmacies around the country. Furthermore, Saudi Arabia is heavily reliant on pharmaceutical imports from diverse geographies, which are mostly dominated by global pharmaceutical behemoths that supply innovative and second-tier brands through local companies. Brand loyalty for multinational firm products can be related to the medication’s quality and accessibility, which helps multinational players get a bigger market share. This report studies Middle East and Africa Refrigerants market dynamics elaborately to identify the current market trends and drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Middle East and Africa Refrigerants market report includes competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Middle East and Africa Refrigerants market to better equip clients with possible investment opportunities across the Countries (Country Investment Hot-Spots) and market unmet needs (Product Opportunities).

Saudi Arabia Pharmaceuticals Market

MARKET SUMMARY
-
6.8%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR–6.8%

Saudi Arabia Pharmaceuticals Market

  • Saudi Arabia Pharmaceuticals Market report gives comprehensive outlook on Pharmaceuticals Market across the regions of Saudi Arabia.
  • The report on Saudi Arabia Pharmaceuticals Market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application and country.
  • Key stakeholders of the Saudi Arabia Pharmaceuticals Market report include suppliers, manufacturers, marketers, policy makers, and recent market activities.
key players
  • GlaxoSmithKline plc. (UK)
  • Jamjoom Pharma (Saudi Arabia)
  • Juphar (UAE)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (US)
Saudi Arabia Pharmaceuticals Market

DRIVERS AND RESTRAINTS

Saudi Arabia Pharmaceuticals Market DRIVERS : The preference for branded drugs or second brands among key stakeholders such as patients and prescribers are creating the ample opportunities for multinational players in the country. These brands generally sold through the alliance with local pharmaceutical companies which help the new players in the market to reach wider pharmacies across the country. Moreover, Saudi Arabia largely dependent upon imports for pharmaceuticals from various geographies and mainly dominated by the multinational pharmaceutical giants who offer innovative and second brands through local players. Brand loyalty for multinational company products can be attributed to the quality and accessibility of the medication which helps in garnering larger market share by multinational players.

Rising prevalence of various chronic diseases such as diabetes, ischemic heart disease, stroke, obesity, hypertension, cancer among Saudi nationals is creating market demand pharmaceuticals in the country. Drug treating chronic ailments are expected to provide lucrative market opportunities for the players in the country. Moreover, these chronic diseases are a major cause of death in Saudi Arabia.


Saudi Arabia got significant share

Saudi Arabia Pharmaceuticals Market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Findings of the Report

  • Saudi Arabia pharmaceuticals market expanding at 6.9% CAGR over 2022 to 2028 to reach market value of US$ 12,646.10 Mn by 2028
  • Based on product type prescription products accounted for larger market revenue share in 2021
  • Hospital pharmacies are prime distribution channel for pharmaceuticals Saudi Arabia
  • Players focusing on expanding product portfolio to garner growing market opportunities

 


Key

Features of the Report

Saudi Arabia Pharmaceuticals Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Research Methodology

      1.1. Secondary and Primary research
            1.1.1. Secondary Sources
            1.1.2. Primary Sources
      1.2. Market Revenue Estimation Methodology
      1.3. Key Assumptions

      1.4. Acronyms

2. Scope of Study

      2.1. Market Definition
      2.2. Objective of the Research

      2.3. Regions covered in the study

3. Executive summary

4. Saudi Arabia Pharmaceuticals Market Dynamics

      4.1. Drivers
            4.1.1. Economic Drivers
            4.1.2. Demand Side Drivers
            4.1.3. Supply Side Drivers
      4.2. Restraints
      4.3. Opportunities/Unmet Needs of the Market

      4.4. Trends

5. Unique Features of the Report

      5.1. Competition analysis
      5.2. Regulatory landscape
      5.3. PESTLE analysis

      5.4. Porter’s analysis

6. Saudi Arabia Pharmaceuticals Market Analysis, By Product Type, 2015 – 2019 and Forecast, 2020 – 2026

      6.1. Prescription Products
            6.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
            6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
      6.2. OTC Products
            6.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)

            6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

7. Saudi Arabia Pharmaceuticals Market Forecast, By Disease Type Analysis, 2015 – 2019 and Forecast, 2020 – 2026

      7.1. Diabetes
            7.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
            7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
      7.2. Cardiovascular Diseases
            7.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
            7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
      7.3. Cancer
            7.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
            7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
      7.4. Neurological Disorders
            7.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
            7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
      7.5. Obesity
            7.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
            7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
      7.6. Infectious Diseases
            7.6.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
            7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
      7.7. Others
            7.7.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)

            7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

8. Saudi Arabia Pharmaceuticals Market Forecast, By Distribution Channel Analysis, 2015 – 2019 and Forecast, 2020 – 2026

      8.1. Hospital Pharmacies
            8.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
            8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
      8.2. Retail Pharmacies
            8.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)

            8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

9. Competition Landscape

      9.1. Strategic Dashboard of Top Market Players
      9.2. Company Profiles (Introduction, Financial Analysis, Component & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
            9.2.1. GlaxoSmithKline plc. (UK)
            9.2.2. Jamjoom Pharma (Saudi Arabia)
            9.2.3. Juphar (UAE)
            9.2.4. Novartis AG (Switzerland)
            9.2.5. Pfizer Inc. (US)
            9.2.6. Riyadh Pharma (Saudi Arabia)
            9.2.7. Sanofi (France)
            9.2.8. SPIMACO (Saudi Arabia)

            9.2.9. Tabuk Pharmaceuticals Manufacturing Co. (Saudi Arabia)


Report

Company Profile

  • GlaxoSmithKline plc. (UK)
  • Jamjoom Pharma (Saudi Arabia)
  • Juphar (UAE)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (US)
  • Riyadh Pharma (Saudi Arabia)
  • Sanofi (France)
  • SPIMACO (Saudi Arabia)
  • Tabuk Pharmaceuticals Manufacturing Co. (Saudi Arabia)

Description

Saudi Arabia Pharmaceuticals Market size was valued at USD 7,979.17 million in 2021 and is expected to reach USD 12,646.10 million by 2028, at a CAGR of 6.8% during the forecast period 2022 to 2028. The desire for branded or second-generation pharmaceuticals among key stakeholders such as patients and prescribers is creating a plethora of opportunities for global companies in the country. These brands are typically distributed through partnerships with local pharmaceutical businesses, which enable new entrants into the market to access a larger number of pharmacies around the country. Furthermore, Saudi Arabia is heavily reliant on pharmaceutical imports from diverse geographies, which are mostly dominated by global pharmaceutical behemoths that supply innovative and second-tier brands through local companies. Brand loyalty for multinational firm products can be related to the medication’s quality and accessibility, which helps multinational players get a bigger market share. This report studies Middle East and Africa Refrigerants market dynamics elaborately to identify the current market trends and drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Middle East and Africa Refrigerants market report includes competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Middle East and Africa Refrigerants market to better equip clients with possible investment opportunities across the Countries (Country Investment Hot-Spots) and market unmet needs (Product Opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX